Furthermore, several perfectly founded adverse prognostic markers, such as U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, missing their negative impact in patients treated with VO. The one variable that remained predictive of the shorter progression-free of charge survival In this particular cohort of patients was TP53 aberrations.112 At last, the alternative https://linkalternatifmbl7777554.activablog.com/30800638/the-2-minute-rule-for-mbl77